3647 results for «698»
3647 results
Management of stable CAD
20 May 2026 – From EuroPCR 2026
This session provides an in-depth review of current management strategies for stable coronary artery disease (CAD). Topics include angiographic predictors influencing PCI efficacy in stable angina, comparative outcomes of immediate versus staged PCI, and analyses of treatment approaches for significant left anterior descending artery disease. The...
Rescue techniques for coronary interventions
20 May 2026 – From EuroPCR 2026
This session presents an array of advanced rescue techniques employed in coronary interventions when unexpected complications arise. It features real-world cases including management of complex coronary artery aneurysms, malignant pericardial tamponade, challenging primary PCI scenarios, and innovative bailout strategies such as self-made covered stents and guidewire...
Rethinking coronary artery disease: from ischaemia to atheroma - Implications of the Lancet Commission for Interventional Cardiology
20 May 2026 – From EuroPCR 2026
This session invites a re-evaluation of coronary artery disease by shifting focus from ischemia to atheroma, integrating insights from the Lancet Commission for Interventional Cardiology. It explores the significance of plaque burden, biology, and inflammation in guiding PCI decisions and outlines the future role of PCI...
The value of intravascular imaging in the planning - Optimisation of PCI and dealing with complications
20 May 2026 – From EuroPCR 2026
Highlighting the critical role of intravascular imaging in PCI, this session explores its utility in procedural planning, optimization of outcomes, and identification and management of complications. Through international case studies, it demonstrates how imaging enhances understanding beyond angiography alone and facilitates tailored, effective interventions.
ViV challenges in degenerated sutureless bioprosthesis
08 Apr 2025
Watch this EuroIntervention image to learn how the collision of a TAV device during valve crossing in ViV TAVI can potentially cause instability or dehiscence of the sutureless bioprosthesis, contributing to severe poorly tolerated PVL.
GLORIOUS - Efficacy of restrictive versus liberal oxygenation or Exenatide in patients undergoing coronary artery bypass grafting or aortic valve replacement – a randomised clinical trial
21 Nov 2024
Edoardo Zancanaro provides his take on the GLORIOUS trial presented by Sebastian Wiberg at AHA 2024 in Chicago.
Author
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
